TRT(SH:600085) Bei Jing Shang Bao·2025-12-20 08:02Core Viewpoint - Tongrentang has initiated a special task force to investigate the products involved in a recent controversy regarding "99% high-purity Antarctic krill oil," which allegedly contains false ingredient labeling. The company is taking legal action against the responsible parties to protect consumer rights and brand integrity [5][6]. Group 1 - Tongrentang has ordered the involved distributor, Sichuan Health Pharmaceutical Co., to cease sales of the disputed product and has initiated a full process review and traceability of the product [5][6]. - The company has stated that the product in question was unauthorizedly labeled with "Beijing Tongrentang," which is considered illegal, prompting the company to pursue legal action against the involved enterprises [5][6]. - Tongrentang clarified that it does not hold any equity or investment rights in Sichuan Health Pharmaceutical, which is not a subsidiary of the company, although it is a subsidiary of Tongrentang Group [5][6]. Group 2 - The announcement emphasized that the trademarks "Tongrentang" and "Beijing Tongrentang" are owned by Tongrentang Group, and the company and some subsidiaries are licensed to use these trademarks on their products [6]. - As part of its efforts to protect consumer rights, Tongrentang will conduct a comprehensive investigation into brand usage and clean up any improper trademark usage, while also standardizing the identification of authorized stores on e-commerce platforms [5][6].